Ledger.Open graph →
SEC Form D · filed March 21, 2017

BioClin Therapeutics, Inc

Offering
$30.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN RAMON, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Cory L. Freedland · San Ramon, CADirectorFouad L. Azzam · San Ramon, CADirectorStephen W. Lau · San Ramon, CAExec · DirectorChristian L. Richard · San Ramon, CADirectorJoel L. Jean-Mairet · San Ramon, CADirectorEric D. Emery · San Ramon, CAExecBrent D. Fassett · San Ramon, CAExecJocelyn D. Holash · San Ramon, CAExecJoseph L. Turner · Menlo Park, CADirectorMarten L. Steen · San Ramon, CADirectorCory L. Freedland · San Ramon, CADirectorStephen W. Lau · San Ramon, CAExec · DirectorChristian L. Richard · San Ramon, CADirectorJoel L. Jean-Mairet · San Ramon, CADirectorEric D. Emery · San Ramon, CAExecBrent D. Fassett · San Ramon, CAExecJocelyn D. Holash · San Ramon, CAExecFouad L. Azzam · San Ramon, CADirectorJoseph L. Turner · San Ramon, CADirectorMarten L. Steen · San Ramon, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗